December 24, 2008- Ajinomoto Co., Inc. and Astellas Pharma Inc. announced today that an additional indication for FASTIC Tablet / STARSIS Tablet, a fast-acting postprandial hypoglycemic agent, jointly developed by the two companies for use in combination therapy with thiazolidines has been approved on December 22.
The details can be read here.
No comments:
Post a Comment